Primary hyperoxaluria type 1: Still challenging!

Pediatric Nephrology

Volumn 21, Issue 8, 2006, Pages 1075-1081

  Cochat, Pierre ^a,b   Liutkus, Aurélia ^a   Fargue, Sonia ^a   Basmaison, Odile ^a   Ranchin, Bruno ^a   Rolland, Marie Odile ^a,c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL DEBROUSSE   (France)

Author keywords

Alanine: Glyoxylate aminotransferase; Combined liver kidney transplantation; Dialysis; Liver transplantation; Oxalate; Oxalosis; Primary hyperoxaluria type 1; Urolithiasis

Indexed keywords

ALANINE GLYOXYLATE AMINOTRANSFERASE; CALCIUM OXALATE; CITRATE POTASSIUM; CITRATE SODIUM; CITRIC ACID; FUROSEMIDE; GLYCOLIC ACID; OXALIC ACID; PHOSPHATE; PROBIOTIC AGENT; PYRIDOXAMINE; PYRIDOXINE; THIAZIDE DIURETIC AGENT;

AUTOSOMAL RECESSIVE DISORDER; CADAVER DONOR; CADAVER KIDNEY; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CRYSTALLIZATION; DIALYSIS; DNA DETERMINATION; ECHOGRAPHY; ENZYME ACTIVITY; ENZYME ASSAY; EXTRACORPOREAL LITHOTRIPSY; GLOMERULUS FILTRATION RATE; HUMAN; HYDRATION; KIDNEY CALCIFICATION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIVER BIOPSY; LIVER TRANSPLANTATION; LIVING DONOR; NONHUMAN; OXALOBACTER FORMIGENES; OXALOSIS 1; PATHOGENESIS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK REDUCTION; STENT; SURVIVAL; TREATMENT FAILURE; URINE LEVEL; UROLITHIASIS;

CHILD; HUMANS; HYPEROXALURIA, PRIMARY;

EID: 33746144049     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-006-0124-4     Document Type: Review

References (43)

1. Cochat P, Deloraine A, Rotily M, Olive F, Liponski I, Deries N, on behalf of the Société de Néphrologie and the Société de Néphrologie Pédiatrique (1995) Epidemiology of primary hyperoxaluria type 1. Nephrol Dial Transplant 10 [Suppl 8]:3-7
2. Lieske JC, Monico CG, Holmes WS, Bergstralh EJ, Slezak JM, Rohlinger AL, Olson JB, Milliner DS (2005) International registry for primary hyperoxaluria. Am J Nephrol 25:290-296
3. Al-Eisa AA, Samhan M, Naseef M (2004) End-stage renal disease in Kuwaiti children: An 8-year experience. Transplant Proc 36:1788-1791
4. Kamoun A, Lakhoua R (1996) End-stage renal disease of the Tunisian child: Epidemiology, etiologies and outcome. Pediatr Nephrol 10:479-482
5. Cochat P, Koch Nogueira PC, Mahmoud AM, Jamieson NV, Scheinman JI, Rolland MO (1999) Primary hyperoxaluria in infants: Medical, ethical and economic issues. J Pediatr 135:746-750
6. Millan MT, Berquist WE, So SK, Sarwal MM, Wayman KI, Cox KL, Filler G, Salvatierra O Jr, Esquivel CO (2003) One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: A single-center experience. Transplantation 76:1458-1463
7. Cochat P, Rolland MO (2005) The primary hyperoxalurias. In: Davison AM, Cameron JS, Grünfeld JP, Ponticelli C, Ritz E, Winearls CG, van Ypersele C (eds) Oxford textbook of clinical nephrology (3rd edn). Oxford University Press, Oxford, pp 2374-2380
8. Danpure CJ (2005) Molecular etiology of primary hyperoxaluria type 1: new directions for treatment. Am J Nephrol 25:303-310
9. Daudon M, Jungers P (2004) Clinical value of crystalluria and quantitative morphoconstitutional analysis of urinary calculi. Nephron Physiol 98:31-36
10. Wong PN, Law ELK, Tong GMW, Mak SK, Lo KY, Wong AKM (2003) Diagnosis of primary hyperoxaluria type 1 by determination of peritoneal dialysate glycolic acid using standard organic-acids analysis method. Perit Dial Int 23:S210-S213
11. Coulter-Mackie MB, Rumsby G (2004) Genetic heterogeneity in primary hyperoxaluria type 1: Impact on diagnosis. Mol Genet Metab 83:38-46
12. Amoroso A, Pirulli D, Florian F, Puzzer D, Boniotto M, Crovella S, Zezlina S, Spano A, Mazzola G, Savoldi S, Ferrettini C, Berutti S, Petrarulo M (2001) AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria. J Am Soc Nephrol 12:2072-2079
13. Marangella M, Vitale C, Petrarulo M, Tricerri A, Cerelli E, Cadario A, Barbos MP, Linari F (1995) Bony content of oxalate in patients with primary hyperoxaluria or oxalosis-unrelated renal failure. Kidney Int 48:182-187
14. Danpure CJ, Rumsby G (1995) Enzymological and molecular genetics of primary hyperoxaluria type 1. Consequences for clinical management. In: Khan SR (ed) Calcium oxalate in biological systems. CRC Press, Boca Raton, pp 189-205
15. Leumann E, Hoppe B (2005) Primary hyperoxaluria type 1: Is genotyping clinically helpful? Pediatr Nephrol 20:555-557
16. Coulter-Mackie MB, Applegarth D, Toone JR, Henderson H (2004) The major allele of the alanine:gLyoxSlate aminotransferase gene: seven novel mutations causing primary hyperoxaluria. Mol Genet Metab 82:64-68
17. Danpure CJ (2004) Molecular aetiology of primary hyperoxaluria type 1. Nephron Exp Nephrol 98:e39-e44
18. Lumb MJ, Danpure CJ (2000) Functional synergism between the most common polymorphism in human alanine:gLyoxylate aminotransferase and four of the most common disease-causing mutations. J Biol Chem 275:36415-36422
19. Monico CG, Persson M, Ford GC, Rumsby G, Milliner DS (2002) Potential mechanisms of marked hyperoxaluria not due to primary hyperoxaluria I or II. Kidney Int 62:392-400
20. Nogueira PC, Vuong TS, Bouton O, Maillard A, Marchand M, Rolland MO, Cochat P, Bozon D (2000) Partial deletion of the AGXT gene (EX1_EX7del): a new genotype in hyperoxaluria type 1. Hum Mutat 15:384-385
21. Rumsby G, Williams E, Coulter-Mackie M (2004) Evaluation of mutation screening as a first line test for the diagnosis of primary hyperoxaluria. Kidney Int 66:959-96323
22. Basmaison O, Rolland MO, Cochat P, Bozon D (2000) Identification of 5 novel mutations in the AGXT gene. Hum Mutat 15:577
23. van Woerden CS, Groothoff JW, Wijburg FA, Annink C, Wanders RJ, Waterham HR (2004) Clinical implications of mutation analysis in primary hyperoxaluria type 1. Kidney Int 66:746-752
24. Monico CG, Rossetti S, Olson JB, Milliner DS (2005) Pyridoxine effect in type I primary hyperoxaluria is associated with the most common mutant allele. Kidney Int 67:1704-1709
25. Coulter-Mackie MB (2005) Preliminary evidence for ethnic differences in primary hyperoxaluria type 1 genotype. Am J Nephrol 25:264-268
26. von Schnakenburg C, Hulton SA, Milford DV, Roper HP, Rumsby G (1998) Variable presentation of primary hyperoxaluria type 1 in 2 patients homozygous for a novel combined deletion and insertion mutation in exon 8 of the AGXT gene. Nephron 78:485-488
27. Leumann E, Hoppe B (2001) The primary hyperoxalurias. J Am Soc Nephrol 12:1986-1993
28. Milliner DS, Wilson DM, Smith LH (2001) Phenotypic expression of primary hyperoxaluria: Comparative features of types I and II. Kidney Int 2001 59:31-36
29. Marangella M, Petrarulo M, Cosseddu D, Vitale C, Linari F (1992) Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria. Am J Kidney Dis 19:546-553
30. Hoppe B, Kemper MJ, Bokenkamp A, Portale A, Cohn R, Langman C (1999) Plasma calcium oxalate super saturation in children with primary hyperoxaluria and end-stage renal failure. Kidney Int 56:268-274
31. Yamauchi T, Quillard M, Takahasi S, Nguyen-Khoa M (2001) Oxalate removal by daily dialysis in a patient with primary hyperoxaluria type 1. Nephrol Dial Transplant 16:2407-2411
32. Scheinman JI, Najarian JS, Mauer SM (1984) Successful strategies for renal transplantation in primary oxalosis. Kidney Int 25:804-811
33. Behnke B, Kemper MJ, Kruse HP, Müller-Wiefel DE (2001) Bone mineral density in children with primary hyperoxaluria type 1. Nephrol Dial Transplant 16:2236-2239
34. Cibrik DM, Kaplan B, Arndorfer JA, Meier-Kriesche HU (2002) Renal allograft survival in patients with oxalosis. Transplantation 74:707-710
35. Jamieson NV (2005) A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): The European PH1 transplant registry experience 1984-2004. Am J Nephrol 25:282-289
36. Cochat P, Schärer K (1993) Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1? Pediatr Nephrol 7:212-218
37. Kemper MJ (2005) The role of preemptive liver transplantation in primary hyperoxaluria type 1. Urol Res 33:376-379
38. Gagnadoux MF, Lacaille F, Niaudet P, Revillon Y, Jouvet P, Jan D, Guest G, Charbit M, Broyer M (2001) Long term results of liver-kidney transplantation in children with primary hyperoxaluria. Pediatr Nephrol 16:946-950
39. Ellis SR, Hulton SA, McKiernan PJ, de Ville de Goyet J, Kelly DA (2001) Combined liver-kidney transplantation for primary hyperoxaluria in young children. Nephrol Dial Transplant 16:348-354
40. Sidhu H, Hoppe B, Hesse A, Tenbrock K, Bromme S, Rietschel E, Peck AB (1998) Absence of Oxalobacter formigenes in cystic fibrosis patients: A risk factor for hyperoxaluria. Lancet 352:1026-1029
41. Chetyrkin SV, Kim D, Belmont JM, Scheinman JI, Hudson BG, Voziyan PA (2004) Pyridoxamine lowers kidney crystals in experimental hyperoxaluria: A potential therapy for primary hyperoxaluria. Kidney Int 67:53-60
42. Danpure CJ (2005) Primary hyperoxaluria: From gene defects to designer drugs? Nephrol Dial Transplant 20:1525-1529
43. Koul S, Johnson T, Pramanik S, Koul H (2005) Cellular transfection to deliver alanine-glyoxylate aminotransferase to hepatocytes: A rational gene therapy for primary hyperoxaluria-1 (PH-1). Am J Nephrol 25:176-182